BUILDING A HEALTHIER STATE
BUILDING A HEALTHIER STATE
PHARMACEUTICALS
Madhya Pradesh Trade and Investment Facilitation Corporation Limited (MPTRIFAC)AVN Towers,192, Zone -1, M.P Nagar, Bhopal 462011Tel.: (+91) 755 4270246. Fax: (+91) 755 2559973. E-mail: [email protected] Website: www.investmp.com National Partner Knowledge Partner
• Growing Pharmaceutical Industry– Indian Scenario
• Our Edge – Madhya Pradesh Scenario – World Class Infrastructure– Access to Skilled Manpower– Government’s Proactiveness
• Opportunities• Key Players
ContentContent
Indian Scenario
Growing Pharmaceutical IndustryPharmaceutical• Market Size: The Indian pharmaceutical industry (USD 12 billion)
was ranked 3rd in terms of volume and 14th in terms of value globally in 2013-14
• Major Drivers: Cost Efficiency, diversified portfolio, including 60,000 generic brands and strong policy support in the form of “Pharma Vision 2020” position India as the global leader in end-to-end drug manufacturing
• Market Segmentation: Divided into four major segments – Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Formulations and Biosimilars with APIs being the largest segment
• Growth in Exports: Pharmaceuticals exports have witnessed a growth of CAGR 26.1% to USD 10.1 billion during FY 06-13
2.4 3.2
4.2 5.1 5.2
6.7
8.5
10.1
0.4 0.6 0.7 0.9 1.1 1.2 1.7 1.8
0
2
4
6
8
10
12
FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13
Export/Import Data of Indian Pharmaceutical Industry (in USD Billion)
Source: Department of Commerce, India, Planning Commission Report
71%
13%
9%
4% 3%
Market Break-up by Segment (FY13)
Hospitals
Pharmaceutical
Medical Equipment & Supplies
Medical Insurance
Diagnostics
• Untapped opportunity: The pharmaceutical sector in Madhya Pradesh offers huge untapped opportunity due to large population base in the state
• Turnover: The Pharmaceutical industry in Madhya Pradesh has an annual turnover of about USD 1.5 billion
• Locational advantage: Being at the centre of the country provides equal access to markets around the country for the pharmaceutical industry
• Large number of pharmaceutical and healthcare units: More than 350 pharmaceutical units located across Madhya Pradesh, out of which 160 are formulation manufacturers
• Major employer: Provides direct and indirect employment to more than 45,000 people
• Robust infrastructure support: The presence of pharmaceutical clusters with a large number of pharmaceutical ancillary units in Pithampur, Indore, Dewas, Mandideep, Bhopal and Ujjain provide a strong infrastructure support for the sector
Indore: Pharmaceutical hub of the state• Indore is one of the largest producers of pharmaceuticals like basic drug formulations, tableting,
capsuling etc.
• Indore houses one of India’s biggest pharmaceutical trade house, “Dawa Bazar”
• Dawa Bazar host a large number of wholesale and retail outlets of small manufacturers, and several multinational pharma companies have their marketing offices here
Pharmaceutical
Over 160 formulation manufactures in Madhya Pradesh
Our Edge
Madhya Pradesh Scenario
World Class Infrastructure
• The pharmaceutical cluster encompasses the industrial estates within Indore, and the industrial regions of Dewas, Ujjain and Pithampur (Dhar district).
Indore, Pithampur SEZ
Proposed Biotechnology Park
• The first SEZ in India – Indore, Pithampur SEZ became operational in August 2003• It is spread over an area of more than 1,100 hectares comprising Phase I and II, housing sectors
such as pharmaceuticals, plastic, engineering, metal, textile and food processing
• 181 acre Biotechnology Park proposed in Indore to be set up under PPP mode• To include amenities like incubation centre, pilot plants, business enterprises zone, warehouses,
healthcare centre etc.• Besides biotechnology, it will host industrial units of pharmaceuticals, agriculture and food processing
Pharmaceutical Infrastructure Scenario
BhindMorena
DatiaSheopur
Shivpuri
Guna AshokNagarNeemuch
Mandsaur
Ratlam
Jhabua
AlirajpurDhar
Dewas
KhargoneBarwani
Khandwa
Burhanpur
Harda
Hoshangabad
Betul
ChhindwaraSeoni
Balaghat
MandlaDindori
Narsinghpur
Shajapur
Sehore
Raisen
TikamgarhRewaChhatarpur
Panna
DamohSagarVidishaRajgarh
Satna
Sidhi
Singrauli
Katni
Umaria Shahdol
Anuppur
Gwalior
Ujjain
Indore
Jabalpur
Bhopal
Above 25 units
No of units: 11 to 25
No of units: 6 to 10
No of units: 1 to 5
Existing Pharmaceutical Cluster
Our Edge
Availability of Skilled Manpower
• Dr.Hari SinghGourCentralUniversity, Sagar has apharmaceutical centre of excellence, and it was the 3rd of its kind in India and the firstinMadhyaPradesh
• Madhya Pradesh is home toIISER,anditprovidesadvancedcoursesinBiologicalSciences
Preparing a large pool of quality workforce
• Number of colleges running pharmacy courses has increased from 20 in FY03 to 111 in FY14
• Intake of students in pharmacy colleges has also witnessed a significant increase from 1150 to 8340 in the same period
Source: Department of Technical Education and Skills Development
Key pharmaceutical colleges in Madhya Pradesh
B. R. Nahata College of Pharmacy, Mandsaur
Indore Institute of Pharmacy, Indore
Department of Pharmacy, Barkatullah University, Bhopal
RGPV School of Pharmaceutical Sciences
SGSITS, Department of Pharmacy, Indore
Our Edge
1150
8340
0
5000
10000
FY03 FY14
Intake Capacity
No. of Institutions - 20
No. of Institutions - 111
Government Proactiveness
Infrastructure Framework• Seven Audyogik Kendra Vikas Nigam(AKVN) established to promote
industrialisation by providing industrial infrastructure• 19 Industrial Growth Centres under 7 AKVNs• Pharmaceutical SEZ at Pithampur under AKVN, Indore• 185 Industrial Areas under District Trade & Industrial Centres(DTIC)
SpecialIncentivesforPharmaceuticals&HerbalIndustriesinHealthcareInvestmentPolicy2012• 50% of the expenditure incurred on technical services for obtaining
GMP certification• Speedy disposal and facilitation• Herbal & Ayurvedic Parks and demonstration centres would be
developed• Herbal & Ayurvedic industries set up in advanced districts will be
provided similar incentives as available in Backward ‘A’ category districts
Investor-friendly Policies • Exemption from Electricity duty• Concession on land• Interest subsidy • VAT & CST reimbursement• Entry Tax exemption• The incentive package shall also be extended to vendor
units, similar to mother units• SmallScale&MediumScalePharmaceuticalUnitshaving
FCIofoverINR50lakhwillbegivenspecialsubsidy
SingleWindowFacilitator• Online Single Window System for Investor Facilitation
& Approval Monitoring System
Presence of Robust Support System
Our Edge
Opportunities
Rising Investment Prospects
Investment Opportunities in Indicative Projects• Bulk Drugs and Active Pharmaceutical Ingredients (API) manufacturing units• Integrated R&D Centre• Drug packaging• Bulk drug manufacturing• Development of medical devices • Herbal production• Cosmetic units• Clinical trial centre• Pharmaceutical Special Economic Zone
Investment Opportunities Across Value Chain
Target Identification
LeadIdentification
Pre-ClinicalTrials
Clinical Trials Manufacturing Packaging Storage & Distribution
Research Testing Delivery
Key Players
Ranbaxy Laboratories Ltd.-RanbaxyLaboratoriesLtd.isanIndianmultinationalpharmaceuticalcompanythatwasincorporatedinIndiain1961
-Highestnumberofbrandsinthe‘Top-30’oftheIndianpharmaceutical market
-Over200moleculesinproduction
-InvestmentinMadhyaPradesh(inINRCrore):9905
Lupin Limited- Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and
branded formulations and APIs
-Productsreachover100countriesandhasemergedasthe5thlargestcompanyintheUS
- In Madhya Pradesh, it has two manufacturing plants – Mandideep for APIs and Indore for formulations
The Piramal Group-ThePiramalGroupoperatesacrosssectorssuchashealthcare,life sciences, drug discovery, healthcare information management,
specialty glass packaging and real estate
- Piramal healthcare offers products for ailments such as acute care, biotech, cardiac, diabetes and orthopaedic
- Third largest player in the global Inhalation Anaesthesia (IA) market, and the only company in the world with a complete productportfolioofinhalationanaestheticsdrugs.ThecompanyhasafacilityinPithampur,Dhar.
Cipla-Ciplaisoneoftheworld’slargestgenericpharmaceuticalcompanieswithapresenceinover170countries
- Offers a broad spectrum of pharmaceutical and surgical products
-Over2000products,65therapeuticcategories,over40 dosage forms
-HasamanufacturingfacilityinIndoreproducingaerosols,liquidorals,pre-filledsyringes,nasalsprays,eyedropsandtablets
Teva- Teva is the largest generic drug manufacturer in the world and offers a wide range of products such as APIs, generic drugs, Oncologysupportetc.
- In Madhya Pradesh, it has a large API manufacturing unit in Malanpur,DistrictBhind
Illustrative List of Pharmaceutical Players* in Madhya Pradesh
Key Contact Principal Secretary
Department of Public Health & Family Welfare, Govt. of Madhya Pradesh
(Off.) 0755-2441074(Fax) 0755-2571399
Email: [email protected]
Managing DirectorMP Trade and Investment Facilitation Corporation Limited
(Government of Madhya Pradesh Undertaking)(Off.) 0755-4270246, 2559978-79
(Fax) 0755-2559973, 2559971Email: [email protected], [email protected]
*This is only a representative list of pharma players present in Madhya Pradesh